ASKA gains exclusive Japanese rights to MHB018A, with Minghui receiving $110 million upfront and eligibility for up to $330 ...

Zuellig Pharma, a leading healthcare solutions company in Asia, announced the strategic acquisition of a specialized clinical ...

Figure 1. Ownership flow for the 21 APAC-origin ADCs in Phase 3 or registrational trials. Left: originator. Right: holder of ...

Mr Ng Tian Chong, Chief Executive Officer, Singtel Singapore; Professor Yeoh Khay Guan, Chief Executive, NUHS; and Mr Daniel ...

Differentia Bio, a developer of AI-powered human disease digital twins, announced that therapeutic mechanisms identified by ...

Neurophet, an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced a ...

Lonza acquires five CDMO manufacturing sites and approximately 1,100 highly skilled employees, more than doubling its US ...

JH2-selective TYK2 inhibitor meets primary and key secondary endpoints, with over 80% of patients achieving clear or almost ...

Laboratoires Pierre Fabre Singapore is delighted to announce the access for patients to BRAFTOVI® (encorafenib) in ...

Under the terms of this agreement, the aggregated potential transaction value, including development, commercial, regulatory ...

Farrer Park Hospital (FPH) announced the introduction of the Edge® Multi-Port Endoscopic Surgical Robot (MP1000) in Singapore ...

The commercial list moved the other way. Sixty-two products applied and 58 passed formal review. In 2025 the same stage had ...